Labeling Changes For Products In Strategic National Stockpile To Be Controlled By FDA, Not Firms

Final rule allows CDC officials to request waivers or alternatives to labeling of certain medical products in a national emergency. Industry had wanted to narrow the waiver powers; hospitals had wanted to broaden them. FDA declined to do either.